Login / Signup

PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.

Diane E MarsmanThomas E BolhuisNathan den BroederAlfons A den BroederAatke van der Maas
Published in: Trials (2022)
Dutch Trial Registration, NL8366 . Registered on 10 February 2020.
Keyphrases
  • double blind
  • phase iii
  • clinical trial
  • study protocol
  • placebo controlled
  • phase ii
  • giant cell
  • randomized controlled trial
  • open label
  • cross sectional
  • combination therapy
  • low dose
  • replacement therapy